Related Experiment Video
Updated: Feb 8, 2026

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
Published on: April 25, 2025
Cellular and molecular mechanisms of kidney fibrosis
1Institute of Pathology, RWTH University of Aachen, Germany.
Abstract:
Renal fibrosis is the final pathological process common to any ongoing, chronic kidney injury or maladaptive repair. It is considered as the underlying pathological process of chronic kidney disease (CKD), which affects more than 10% of world population and for which treatment options are limited. Renal fibrosis is defined by excessive deposition of extracellular matrix, which disrupts and replaces the functional parenchyma that leads to organ failure. Kidney's histological structure can be divided into three main compartments, all of which can be affected by fibrosis, specifically termed glomerulosclerosis in glomeruli, interstitial fibrosis in tubulointerstitium and arteriosclerosis and perivascular fibrosis in vasculature. In this review, we summarized the different appearance, cellular origin and major emerging processes and mediators of fibrosis in each compartment. We also depicted and discussed the challenges in translation of anti-fibrotic treatment to clinical practice and discuss possible solutions and future directions.
Insights
Renal fibrosis, a key process in chronic kidney disease (CKD), involves excessive matrix deposition that impairs kidney function. This review details fibrosis in different kidney compartments and discusses anti-fibrotic treatment challenges.
Area of Science:
- Nephrology
- Pathology
- Translational Medicine
Background:
- Renal fibrosis is the common endpoint of chronic kidney injury and a primary driver of chronic kidney disease (CKD).
- CKD affects over 10% of the global population, with limited therapeutic options.
- Fibrosis leads to organ failure through excessive extracellular matrix deposition, disrupting kidney parenchyma.
Purpose of the Study:
- To review the diverse manifestations, cellular origins, and key mediators of renal fibrosis across different kidney compartments.
- To analyze the challenges in translating anti-fibrotic therapies into clinical practice.
- To propose solutions and future research directions for combating renal fibrosis.
Main Methods:
- Comprehensive literature review of renal fibrosis.
- Analysis of histological compartments affected by fibrosis: glomeruli, tubulointerstitium, and vasculature.
- Discussion of cellular origins and pathogenic processes.
- Evaluation of clinical translation challenges for anti-fibrotic treatments.
Main Results:
- Fibrosis presents differently in glomeruli (glomerulosclerosis), tubulointerstitium (interstitial fibrosis), and vasculature (arteriosclerosis, perivascular fibrosis).
- Emerging mediators and cellular processes driving fibrosis in each compartment are identified.
- Significant hurdles exist in translating experimental anti-fibrotic strategies to effective clinical treatments.
Conclusions:
- Understanding the specific mechanisms of fibrosis in each kidney compartment is crucial.
- Overcoming clinical translation barriers is essential for developing effective anti-fibrotic therapies.
- Future research should focus on targeted interventions and innovative therapeutic strategies for CKD.
Related Concept Videos
Kidney Structure
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Reaction Mechanisms
For instance, the decomposition of ozone appears to follow a mechanism with two steps:
Molecular Models
Cystic Fibrosis: Management
Sinus disease and chronic...
Molecular Orbital Theory II

